Diabetes Research and Clinical Practice
Volume 62, Issue 1 , Pages 33-38, October 2003

Association of fulminant type 1 diabetes with pregnancy

  • I. Shimizu

      Affiliations

    • Ehime Prefectural Hospital, Ehime, Japan
  • ,
  • H. Makino

      Affiliations

    • Department of Laboratory Medicine, Ehime University School of Medicine, Shigenobu, Ehime 791-0295, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-89-960-5592; fax: +81-89-960-5627
  • ,
  • H. Osawa

      Affiliations

    • Department of Laboratory Medicine, Ehime University School of Medicine, Shigenobu, Ehime 791-0295, Japan
  • ,
  • E. Kounoue

      Affiliations

    • Matsuyama Red Cross Hospital, Ehime, Japan
  • ,
  • A. Imagawa

      Affiliations

    • Graduate School of Medicine, Osaka University, Osaka, Japan
  • ,
  • T. Hanafusa

      Affiliations

    • Osaka Medical College, Osaka, Japan
  • ,
  • E. Kawasaki

      Affiliations

    • Unit of Metabolism/Diabetes and Clinical Nutrition, Nagasaki University School of Medicine, Nagasaki, Japan
  • ,
  • Y. Fujii

      Affiliations

    • Ehime Prefectural Hospital, Ehime, Japan

Received 23 January 2003; received in revised form 6 May 2003; accepted 13 June 2003.

Abstract 

It has been reported that fulminant type 1 diabetes is a novel subtype of type 1B diabetes. However, whether the etiology of fulminant type 1 diabetes is associated with an autoimmune or nonautoimmune process remains to be solved. In order to further characterize fulminant type 1 diabetes, we compared the clinical, immunological and genetic characteristics with those of acute-onset type 1A diabetes. Nine patients with fulminant diabetes and nine patients with acute-onset type 1A diabetes, who had been newly diagnosed during 1998–2001, were analyzed. In female patients of child-bearing age, the onset of diabetes occurred during pregnancy or after delivery in three cases of six fulminant cases, but not in any of seven type 1A diabetes. Eight of nine fulminant patients had fever immediately prior to the onset of hyperglycemic symptoms, whereas only one of nine type 1A patients had this (P=0.002). In Japanese type 1 susceptible HLA haplotypes, DRB1*0901-DQB1*0303 was more frequent in type 1A diabetes than fulminant diabetes (7/18 vs. 0/18, P=0.004), whereas the frequency of DRB1*0405-DQB1*0401 was similar (type 1A 4/18 vs. fulminant 6/18). Therefore, pregnancy, possible viral infection, or HLADRB1*0405-DQB1*0401 may contribute to the onset of fulminant type 1 diabetes.

Keywords: Fulminant type 1 diabetes, Pregnancy, Viral infection, HLA, GADab

Abbreviations: GADab, GAD autoantibodies, HHV6, human herpes virus-6, ICA, islet cell antibody, IDDM, insulin dependent diabetes mellitus, TG, thyroglobulin, TPO, thyroid peroxidase

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(03)00147-5

doi:10.1016/S0168-8227(03)00147-5

Diabetes Research and Clinical Practice
Volume 62, Issue 1 , Pages 33-38, October 2003